ATLANTA--(BUSINESS WIRE)--Jul. 22, 2015--
Carter’s, Inc. (NYSE:CRI), the largest branded marketer in the United
States and Canada of apparel exclusively for babies and young children,
will report its second quarter fiscal 2015 results before the market
opens on Wednesday, July 29, 2015.
The Company will hold a conference call with investors to discuss these
results and its business outlook on this date at 8:30 a.m. Eastern
Daylight Time. To participate in the call, please dial 913-312-1456. To
listen via the internet, please visit www.carters.com
and select links for “Investor Relations” followed by “Second Quarter
2015 Earnings Conference Call”. Presentation materials for the call can
be accessed under the same “Investor Relations” section by selecting
links for “News & Events” followed by “Webcasts & Presentations”.
A replay of the call will be available shortly after the broadcast
through August 6, 2015, at 888-203-1112 (U.S. / Canada) or 719-457-0820
(international), passcode 2253968. The replay will also be archived on
the Company’s website under the “Investor Relations” tab.
About Carter's, Inc.
Carter's, Inc. is the largest branded marketer in the United States and
Canada of apparel and related products exclusively for babies and young
children. The Company owns the Carter's and OshKosh B'gosh
brands, two of the most recognized brands in the marketplace. These
brands are sold in leading department stores, national chains, and
specialty retailers domestically and internationally. They are also sold
through more than 800 Company-operated stores in the United States and
Canada and on-line at www.carters.com,
The Company's Just One You, Precious Firsts, and Genuine
Kids brands are available at Target, and its Child of Mine
brand is available at Walmart. Carter's is headquartered in Atlanta,
Georgia. Additional information may be found at www.carters.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150722006447/en/
Source: Carter's, Inc.
Sean McHugh, 678-791-7615
Vice President &